Prevention of acute cyclosporine nephrotoxicity by atrial natriuretic factor after ischemia in the rat

Autor: Pierre Gianello, Ramboux A, Poelart D, Jamart J, Berbinschi A, Donckier J, Jm, Ketelslegers, Lambotte L, Jp, Squifflet, Gp, Alexandre

Publikováno v: Europe PubMed Central

The present experimental study investigates whether the atrial natriuretic factor (ANF) is able to prevent the nephrotoxic effects of cyclosporine infused after 30 min of warm renal ischemia in the rat. At 2 hr after the end of ischemia, the glomerul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ed69763c6338ac1dd530ae94818d2ddc
https://pubmed.ncbi.nlm.nih.gov/2522254

Beneficial effect of atrial natriuretic factor on ischemically injured kidneys in rats

Autor: Pierre Gianello, Poelaert D, Ramboux A, Jp, Squifflet, Berbinschi A, Donckier J, Jm, Ketelslegers, Lambotte L, Alexandre G

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9e033bf6396e2c6d60209993c564852b
http://europepmc.org/abstract/med/2973163

Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation

Autor: Pierre Gianello, Carlier M, Jamart J, Hulhoven R, Bernheim J, Bernard A, Jm, Ketelslegers, Jp, Squifflet

Publikováno v: Europe PubMed Central

The efficacy and safety of (1-28) alpha-human ANP in preventing acute tubular necrosis (ATN) in cadaveric renal transplantation was tested by comparing ANP infusion with a maximal hydration (MH) regimen which we previously reported as effective in lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d6184f7f9001ea5e1d65dc26a2be38a5
http://europepmc.org/abstract/med/8645892

Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.

Autor: Olivier A; Inserm, CIC-P 14-33, U 116, CHU Nancy, France; University of Lorraine, France; F-CRIN INI-CRCT, Nancy, France; Department of Cardiovascular Disease, Institut Lorrain du Coeur et des Vaisseaux, Nancy University Hospital, Nancy, France. Electronic address: a.olivier@chru-nancy.fr., Girerd N; Inserm, CIC-P 14-33, U 116, CHU Nancy, France; University of Lorraine, France; F-CRIN INI-CRCT, Nancy, France., Michel JB; Inserm, UMRS 1148 University Paris Diderot, Paris, France., Ketelslegers JM; Université Catholique de Louvain, Brussels, Belgium., Fay R; Inserm, CIC-P 14-33, U 116, CHU Nancy, France; University of Lorraine, France; F-CRIN INI-CRCT, Nancy, France., Vincent J; Pfizer Inc., New York, USA., Bramlage P; Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, Germany., Pitt B; University of Michigan, School of Medicine, Ann Arbor, MI, USA., Zannad F; Inserm, CIC-P 14-33, U 116, CHU Nancy, France; University of Lorraine, France; F-CRIN INI-CRCT, Nancy, France; Department of Cardiovascular Disease, Institut Lorrain du Coeur et des Vaisseaux, Nancy University Hospital, Nancy, France., Rossignol P; Inserm, CIC-P 14-33, U 116, CHU Nancy, France; University of Lorraine, France; F-CRIN INI-CRCT, Nancy, France.

Publikováno v: International journal of cardiology [Int J Cardiol] 2017 Aug 15; Vol. 241, pp. 344-350. Date of Electronic Publication: 2017 Feb 08.

Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure.

Autor: Gruson D; Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Brussels, Belgium. damien.gruson@uclouvain.be, Lepoutre T, Ahn SA, Ketelslegers JM, Rousseau MF

Publikováno v: Journal of endocrinological investigation [J Endocrinol Invest] 2012 Dec; Vol. 35 (11), pp. 987-91. Date of Electronic Publication: 2012 Feb 28.